Impact of reproductive status and age on response of depressed women to cognitive therapy

Journal of Women's Health

Volumn 22, Issue 1, 2013, Pages 58-66

  Brandon, Anna R ^a,b   Minhajuddin, Abu ^b   Thase, Michael E ^c   Jarrett, Robin B ^b  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^c UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; COGNITIVE THERAPY; DSM-IV; FEMALE; HAMILTON SCALE; HUMAN; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MENOPAUSAL SYNDROME; PATIENT COMPLIANCE; PREMENOPAUSE; PRIORITY JOURNAL; RECURRENT DISEASE; REPRODUCTIVE HEALTH; SELF REPORT; TREATMENT DURATION; TREATMENT RESPONSE; WOMEN'S HEALTH;

ADOLESCENT; ADULT; AGE FACTORS; AGED; ANTIDEPRESSIVE AGENTS; COGNITIVE THERAPY; DEPRESSIVE DISORDER, MAJOR; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; FEMALE; HUMANS; LOGISTIC MODELS; MATERNAL AGE; MENOPAUSE; MIDDLE AGED; PSYCHIATRIC STATUS RATING SCALES; REPRODUCTIVE HISTORY; SEVERITY OF ILLNESS INDEX; SOCIOECONOMIC FACTORS; TEXAS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84872304385     PISSN: 15409996     EISSN: 1931843X     Source Type: Journal    
DOI: 10.1089/jwh.2011.3427     Document Type: Article

References (47)

1. Weissman MM, Klerman GL. Sex differences and the epidemiology of depression. Arch Gen Psychiatry 1977;34:98-111.
2. Kessler RC, ed. The epidemiology of depression among women. New York: Cambridge University Press, 2006.
3. Kessler RC. Epidemiology of women and depression. J Affec Disord 2003;74:5-13.
4. Wilhelm K, Parker G, Geerligs L, Wedgwood L. Women and depression: A 30 year learning curve. Aust NZ J Psychiatry 2008;42:3-12.
5. Bromberger JT, Matthews KA, Schott LL, et al. Depressive symptoms during the menopausal transition: The Study of Women's Health Across the Nation (SWAN). J Affect Disord 2007;103:267-272.
6. Bromberger JT, Assmann SF, Avis NE, Schocken M, Kravitz HM, Cordal A. Persistent mood symptoms in a multiethnic community cohort of pre-and perimenopausal women. Am J Epidemiol 2003;158:347-356.
7. Cohen LS, Soares CN, Vitonis AF, Otto MW, Harlow BL. Risk for new onset of depression during the menopausal transition: The Harvard Study of Moods and Cycles. Arch Gen Psychiatry 2006;63:385-390.
8. Freeman EW, Sammel MD, Lin H, Nelson DB. Associations of hormones and menopausal status with depressed mood in women with no history of depression. Arch Gen Psychiatry 2006;63:375-382.
9. Schmidt PJ, Rubinow DR. Reproductive ageing, sex steroids and depression. J Br Menopause Soc 2006;12:178-185.
10. World Health Organization. Research on the menopause in the 1990's: Report of a WHO scientific group. Geneva: WHO, 1996.
11. Rasgon N, Shelton S, Halbreich U. Perimenopausal mental disorders: Epidemiology and phenomenology. CNS Spectr 2005;10:471-478.
12. Kornstein SG, Schatzberg AF, Thase ME, et al. Gender differences in treatment response to sertraline versus imipramine in chronic depression. Am J Psychiatry 2000;157:1445-1452.
13. Kornstein SG. Gender differences in depression: Implications for treatment. J Clin Psychiatry 1997;58 (Suppl 15):12-18.
14. Thase ME, Entsuah R, Cantillon M, Kornstein SG. Relative antidepressant efficacy of venlafaxine and SSRIs: Sex-age interactions. J Womens Health 2005;14:609-616.
15. Cassano P, Soares CN, Cusin C, Mascarini A, Cohen LS, Fava M. Antidepressant response and well-being in pre-, peri-and postmenopausal women with major depressive disorder treated with fluoxetine. Psychother Psychosom 2005;74:362-365.
16. Entsuah AR, Huang H, Thase ME. Response and remission rates in different subpopulations with major depressive disorder administered venlafaxine, selective serotonin reuptake inhibitors, or placebo. J Clin Psychiatry 2001;62: 869-877.
17. Quitkin FM, Stewart JW, McGrath PJ, et al. Are there differences between women's and men's antidepressant responses? Am J Psychiatry 2002;159:1848-1854.
18. Dorsey CM, Lee KA, Scharf MB. Effect of zolpidem on sleep in women with perimenopausal and postmenopausal insomnia: A 4-week, randomized, multicenter, double-blind, placebo-controlled study. Clin Ther 2004;26:1578-1586.
19. Harvey AT, Silkey BS, Kornstein SG, Clary CM. Acute worsening of chronic depression during a double-blind, randomized clinical trial of antidepressant efficacy: Differences by sex and menopausal status. J Clin Psychiatry 2007; 68:951-958.
20. Frank E, Thase ME, Spanier CA, Reynolds CF 3rd, Kupfer DJ. Gender-specific response to depression treatment. J Gend Specific Med 1999;2:40-44.
21. Parker G, Blanch B, Crawford J. Does gender influence response to differing psychotherapies by those with unipolar depression? J Affect Disord 2011;130:17-20.
22. Bromberger JT, Schott LL, Kravitz HM, et al. Longitudinal change in reproductive hormones and depressive symptoms across the menopausal transition: Results from the Study of Women's Health Across the Nation (SWAN). Arch Gen Psychiatry 2010;67:598-607.
23. National Institute of Mental Health. Major depressive disorder in children. Available at www.nimh.nih.gov/statistics/1MDD-CHILD.shtml Accessed August 28, 2012.
24. Medicine HSo. National Comorbidity Survey (NCS): NCS-R lifetime prevalence estimates, 2007. Available at www.hcp .med.harvard.edu/ncs/ftpdir/ NCS-R-Lifetime-Prevalence-Estimates.pdf
25. Jarrett RB, Thase ME. Comparative efficacy and durability of continuation phase cognitive therapy for preventing recurrent depression: Design of a double-blinded, fluoxetine-and pill placebo-controlled, randomized trial with 2-year followup. Contemporary Clin Trials 2010;31:355-377.
26. American Psychiatric Association. Diagnostic and statistical manual of mental disorders, 4th ed. Text revision. Washington, DC: American Psychiatric Association, 2000.
27. Shifren JL, Avis NE. Surgical menopause: Effects on psychological well-being and sexuality. Menopause 2007;14:586-591.
28. Sowers MF, Crawford SL, Sternfeld B, Morganstein D, Gold EB, Greendale GA. SWAN: A multicenter, multiethnic, community-based cohort study of women and the menopause. In: Lobo R, Kelsey J, Marcus R, eds. Menopause: Biology and pathobiology. San Diego, CA: Academic Press, 2000:175-188.
29. Beck JS. Cognitive therapy: Basics and beyond. New York: Guilford Press, 1995.
30. Vallis T, Shaw BF, Dobson KD. The Cognitive Therapy Scale: Psychometric properties. J Consult Clin Psychol 1986;54: 381-385.
31. First MB, Spitzer RL, et al. Structured clinical interview for DSM-IV axis 1 disorders: (Scid 1) Clinician Version. Arlington, VA: American Psychiatric Publishing, Inc., (1997).
32. Summerfeldt LJ, Antony MM. Structured and semistructured diagnostic interviews. New York: Guilford Press, 2002.
33. Brown TA, Di Nardo PA, Lehman CL, Campbell LA. Reliability of DSM-IV anxiety and mood disorders: Implications for the classification of emotional disorders. J Abnorm Psychol 2001;110:49-58.
34. Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatry 1960;23:56-62.
35. Clark LA, Watson D. Tripartite model of anxiety and depression: Psychometric evidence and taxonomic implications. J Abnorm Psychol 1991;100:316-336.
36. Schwab JJ, Bialow MR, Holzer CE. A comparison of two rating scales for depression. J Clin Psychol 1967;23:94-96.
37. Knesevich JW, Biggs JT, Clayton PJ, Ziegler VE. Validity of Hamilton Rating Scale for Depression. Br J Psychiatry 1977; 131:49-52.
38. RushAJ, KraemerHC, SackeimHA, et al.Report by the ACNP Task Force on response and remission in major depressive disorder. Neuropsychopharmacology 2006;31:1841-1853.
39. Hendrick V, Altshuler LL, Burt VK. Course of psychiatric disorders across the menstrual cycle. Harvard Rev Psychiatry 1996;4:200-207.
40. Burt VK, Stein K. Epidemiology of depression throughout the female life cycle. J Clin Psychiatry 2002;63 (Suppl 7):9-15.
41. Koch JM, Hinze-Selch D, Stingele K, et al. Changes in CREB phosphorylation and BDNF plasma levels during psychotherapy of depression. Psychother Psychosom 2009;78: 187-192.
42. Mayberg HS. Defining neurocircuits in depression: Strategies toward treatment selection based on neuroimaging phenotypes. Psychiatr Ann 2006;36:259-268.
43. DeRubeis RJ, Siegle GJ, Hollon SD. Cognitive therapy versus medication for depression: Treatment outcomes and neural mechanisms. Nat Rev Neurosci 2008;9:788-796.
44. Baca E, Garcia-Garcia M, Porras-Chavarino A. Gender differences in treatment response to sertraline versus imipramine in patients with nonmelancholic depressive disorders. Prog Neuro-Psychopharmacol Biol Psychiatry 2004;28: 57-65.
45. Kornstein SG, Wohlreich MM, Mallinckrodt CH, Watkin JG, Stewart DE. Duloxetine efficacy for major depressive disorder in male vs. female patients: Data from 7 randomized, double-blind, placebo-controlled trials. J Clin Psychiatry 2006;67:761-770.
46. Bigos KL, Pollock BG, Stankevich BA, Bies RR. Sex differences in the pharmacokinetics and pharmacodynamics of antidepressants: An updated review. Gend Med 2009;6:522-543.
47. Simon GE, Arterburn D, Rohde P, et al. Obesity, depression, and health services costs among middle-aged women. J Gen Intern Med 2011;26:1284-1290.